WHO says countries need to ‘move from plans to delivery’ on antimicrobial resistance
Chris Dall, MAToday at 3:55 p.m.
Antimicrobial Stewardship
New survey data released today by the World Health Organization (WHO) show that most countries have developed plans to address antimicrobial resistance (AMR). But few have implemented or providing financing for those plans.
The data, from the Tracking AMR Self-assessment Survey (TRaCSS), conducted every year by the WHO and other international agencies engaged in the fight against drug-resistant infections, show that 179 countries (89% of WHO member states) have developed a national AMR action plan, up from 79 (41%) in 2017. But only 42 (22%) have translated those plans into funded programs.
National action plans have been a cornerstone of the WHO’s efforts to address AMR since the United Nations (UN) High-Level Meeting on AMR in 2016. At the follow-up meeting in 2024, member states agreed that, by 2030, at least 60% of countries should have funded AMR action plans.
WHO technical officer Pravarsha Prakash, MS, said at a media briefing this morning that while the number of nations with an AMR action plan shows real progress, “countries now also need to move from plans to delivery.”
Jean Pierre Nyemazi, MD, acting director of the WHO’s AMR Department, said the world is in a pivotal moment in the fight against drug-resistant infections, which were responsible for more than one million deaths, and contributed to nearly five million, in 2021.
“The choices we make now will determine whether future generations inherit a world where common infections are treatable,” Nyemazi said.
Gaps in infection prevention, surveillance, testing
Progress is also slow in other areas assessed in the survey, which was released ahead of World Antimicrobial Awareness Week (November 18 to 24).That includes preventing the infections that drive antibiotic use and AMR. While the number of countries with a national infection prevention and control (IPC) program has risen from 90 (46%) in 2017 to 128 (66%) in 2024, only 36% of those countries have implemented their program—far short of the UN’s 90% goal by 2030.
Likewise, less than 60% of countries have implemented national surveillance systems for antimicrobial use (58%) and AMR (56%), and fewer than one in five countries link data from the two systems. Only 67% report having guidelines on the appropriate use of antimicrobials.
In addition, only 66 countries (36%) have a national reference laboratory that can test resistance in selected bacteria and fungi, which is critical for ensuring that patients are treated with the right antibiotic or antifungal. The 2030 target is for 80% of countries to have this capacity.The choices we make now will determine whether future generations inherit a world where common infections are treatable.
“Even in their best equipped laboratory, typically located in the capital city, more than one in four countries cannot test for resistance in the bacteria monitored,” said Silvia Bertagnolio, MD, head of the WHO’s AMR Surveillance, Evidence and Laboratory Strengthening Unit.
Bertagnolio added that, for hospital patients in many countries, particularly the low-resource countries where resistance rates are highest, the chance of having a bacterial or fungal infection tested is far lower.
“Without testing, clinicians must treat without knowing the cause of infection, or which antibiotic will work,” she said. “Without testing, we cannot see where resistance is emerging.”
To help countries close testing gaps, the WHO also released two additional documents today. One lists the essential diagnostic tests that should be available at different healthcare levels to “support accurate diagnosis, treatment, and surveillance of bacterial infections and antimicrobial resistance.” The other provides clinical laboratories with standard operating procedures for diagnosing bacterial and fungal infections and conducting antimicrobial susceptibility testing.
“A gap anywhere is a risk everywhere, and resistant infections, we know, do not stop at borders,” Bertagnolio said.